Updated: Jul 10, 2008
Facial soft-tissue injuries are not uncommon in athletics.1,2,3,4,5,6,7 The position and anatomy of the face make it particularly vulnerable to trauma. In addition, few sports mandate the use of protective equipment, leaving the face susceptible to injury. Although most such injuries are minor in nature, they should be evaluated promptly with a focused history and thorough examination. In addition, facial injuries should be treated early to reduce the likelihood of possible adverse outcomes (ie, infection, loss of function, poor cosmesis). In this article, common sports-related soft-tissue facial injuries are discussed, with an emphasis on the initial evaluation, diagnosis, and treatment.
For excellent patient education resources, visit eMedicine's Sports Injury Center; Eye and Vision Center; Nosebleeds Center; and Cuts, Scrapes, Bruises, and Blisters Center. Also, see eMedicine's patient education articles Facial Fracture, Black Eye, Nosebleeds, Bicycle and Motorcycle Helmets, and Bicycle Safety.
Related eMedicine topics:
Facial Fractures
Facial Soft Tissue Trauma
Facial Trauma, Sports-Related Injuries
Related Medscape topics:
Resource Center Aesthetic Medicine
Resource Center Exercise and Sports Medicine
Resource Center Sepsis
Resource Center Wound Management
CME/CE Focus on Fractional Laser Resurfacing
CME/CE Highlights of PAS 2008: Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting
Original Articles - Facial Resurfacing With Coblation Technology
Mechanism and Emergency Management of Blast Eye/Orbital Injuries
The exact frequency of facial soft-tissue injuries related to sports participation is unknown. This is, in part, due to the minor nature of many injuries, which can lead to underreporting. It may also be due to the wide variation that is seen between demographic groups and between specific sports.
Previous reports estimate sports participation to account for 3-29% of all facial injuries.5 In terms of overall sports-related injury, facial trauma accounts for 11-40% of injuries attended to by medical professionals. Most injuries are reported in males, particularly those aged 10-29 years. Sports that mandate the use of helmets and face masks tend to have fewer soft-tissue injuries compared with sports that do not mandate the use of such equipment.
The mechanism of facial soft-tissue injuries is often a direct impact from an external source (eg, sporting equipment, another participant, environment/playing surface). The forces exerted by the impact can lead to friction, shear, compression, and/or traction of the soft tissue and underlying structures. Injury patterns vary widely by sport, based on various factors (eg, rules, equipment).
Related Medscape topics:
Resource Center Exercise and Sports Medicine
Resource Center Fracture
Resource Center Trauma
A focused and thorough history should be obtained from the injured athlete, including his or her pertinent medical history, the mechanism of injury (if not witnessed by the medical staff), and the source of pain. If the patient is unable to report history information, family members can provide such information. The presence of symptoms such as visual changes or altered sensorium should also be ascertained at this time.
As with any head and neck injury, examination of an individual with trauma to the face must start with an evaluation of the patient's airway, breathing, and circulation (ABCs). Cervical spine injury should also be considered based on the mechanism of injury, and appropriate precautions should be taken. The physical examination should be focused on the specific injury site.
The face is extremely vascular, and even minor injuries may result in profuse bleeding. Copious irrigation should be used to clean and accurately assess the injury. Visual inspection and palpation should be used to systematically examine the face for symmetry. Start superiorly, with the scalp and frontal bones, and proceed inferiorly and laterally. Examine the oral cavity for any disrupted dentition or lacerations. During inspection, pay particular attention to any areas of swelling because this may indicate a more significant underlying injury.
Note the location, size, shape, and depth of any lacerations, and explore wounds for foreign bodies. Palpate for areas of crepitus or bony step-off. Gross asymmetry may signify underlying nerve damage. Assess neurologic function by evaluating sensation and motor function.
ScalpDue to rich vascularity, the amount of bleeding present may not be proportionate to the size of a soft-tissue injury. This is particularly true of the scalp. After cleaning the wound, hemostasis should be attempted with direct pressure. The areas around any lacerations should be examined for bony step-off that would indicate a possible underlying skull fracture. Try to avoid removing hair at the border of any wound because this helps serve as a landmark for accurate repair and may have important cosmetic implications.
Orbital rim/Eyebrow
Inspect the orbital rim carefully because injury in the area of the eyebrow may indicate the presence of an underlying fracture. The rim should be palpated around its circumference. Subtle displacement of the rim may be identified by placing an index finger on each infraorbital rim and viewing from above or below with the patient's head tilted back. Check carefully for any deficit in sensation in the area. Attempt to maintain the alignment of the brow borders during repair. Never shave the eyebrow because this may result in significant cosmetic deformity. The brow is at significant risk of not growing back or growing back with an abnormal pattern or color.
Eyelids
Simple lacerations of the eyelid, without involvement of the margins, can be treated without concern for further eye injury. If the protective function of the lid is compromised in any way, serious ophthalmologic injury may result. Exploration for foreign bodies must be performed. Flip the eyelids over and examine the tarsal plate. Damage to either side of the tarsal plate should be referred to an ophthalmologist for repair. If ptosis is present, injury to the levator aponeurosis should be suspected, and this injury should also be referred to an ophthalmologist. Additional injuries that warrant an evaluation by an ophthalmologist are any injuries that involve the canthi, lacrimal system, or lid margin.
Eyes
Look for any gross injury or asymmetry in the globes. Check the papillary responses to light directly and indirectly. Using an ophthalmoscope, the anterior chamber should be visualized to look for blood, rupture of the iris, or asymmetry. Examine the cornea and look for foreign bodies, abrasions, tears, or lacerations. Fluorescein dye and tetracaine (or other topical ocular anesthetic) should be used to ensure an adequate examination.
Extraocular movements should be evaluated. Deficits in movement may indicate entrapment or injury to one of the extraocular muscles. Deficits may also indicate injury to one of the nerves that controls globe movement (cranial nerves [CNs] III, IV, and VI). Evaluate for conjugate gaze and smooth pursuit.
Visual acuity should also be assessed. On the sideline or in the locker room, a hand-held eye chart may be used for gross investigation. Significant loss of visual acuity may be due to injury of the globe, retina, or optic nerve or due to an injury that is more central. These injuries are an indication for more urgent ophthalmologic care than can be provided on the sideline, and the patient should be sent to the appropriate facility for definitive care.
Ears
A direct blow or shearing force to the ear may result in tearing of the blood vessels at the level of the perichondrium. The result is a subperichondrial hematoma. These injuries can result in significant cosmetic deformity if missed or if not treated immediately. Fibrosis develops within 2 weeks of the injury, and the athlete can be left with abnormally shaped pinnae (a condition also known as cauliflower ear). Blunt trauma or barotrauma (in specific sports) may cause perforation of the tympanic membrane. An otoscope should be used to visualize the defect and to look for any serous or bloody discharge. Most athletes are asymptomatic, but vertigo and otalgia may be present.
Nose
When the nose is fractured, it usually appears deformed. Nevertheless, epistaxis without obvious nasal deformity may be the only clinical finding in some nasal fractures. Performing an adequate and thorough nasal examination is difficult without epistaxis control. The origin of most nosebleeds is the extremely vascular area on the anterior septum (Kiesselbach area).
Once the bleeding is controlled, intranasal inspection using a nasal speculum should be performed, and the position and integrity of the nasal septum should be noted. The turbinates and inferior meatus should be visualized bilaterally, and the septum should be inspected for the presence of a septal hematoma. Any mucosal lacerations should be noted because they may be a sign of underlying fracture.
The presence of rhinorrhea associated with significant trauma should suggest a possible cerebrospinal fluid (CSF) leak. An athlete may report a very salty taste in the mouth. An easy way to objectively evaluate for a CSF leak is to look for the halo or ring sign. To perform this test, a drop of the rhinorrhea in question is placed on a piece of filter paper. A clear ring around a blood-tinged center is indicative of the presence of CSF. A positive test result may indicate a basilar skull fracture that requires more urgent tertiary care.
Mouth/Lips
Inspect the lips carefully. Any disruption of the vermilion border should be noted; failure to do so can lead to inadequate repair, which can result in significant cosmetic deformity (see Image 4, top). A step-off of the vermilion border as small as 1 mm is apparent at conversational distance.
Inspect the inside of the lip for through-and-through wounds. An intraoral examination is a necessary part of the facial evaluation. The inside of the lips and cheeks should be examined thoroughly for any through-and-through wounds. Special attention should be given to the area around the parotid duct (see Image 1). With any injury involving the mid cheek, an attempt should be made to milk the parotid gland and observe the flow of saliva from the Stensen duct in order to ensure duct patency. Any suspected injury should be referred for possible stenting and repair. Also, look for disrupted teeth and hematoma.
Tongue
Examine the tongue for lacerations; importantly, note the extent of the injury. Most lacerations, however, do not require repair. One exception is a complete anterior laceration, which can result in a bifid tongue if not properly repaired. Through-and-through and deep lacerations should be explored for the presence of foreign bodies and the potential need for repair.
Face
The bones of the face should be inspected for any asymmetry. Palpate all of the bones; be sure to include the temporomandibular joint. The movements of facial expression should be assessed by observing the patient as he or she raises the eyebrows, closes the eyes, smiles, and frowns. Any deficit is suggestive of injury to one of the branches of the facial nerve (CN VII). Examine sensation for each of the 3 branches of the trigeminal nerve (CN V) (see Image 2). Deficits in any area warrant further evaluation. Injuries along a topographic line extending from the tragus to the base of the nose, and lateral to the lateral canthus, should raise the suspicion of a parotid duct injury, and the evaluation should proceed as described above under Mouth/Lips.
Related eMedicine topics:
Cervical Spine Injuries in Sports
Cervical Spine Sprain/Strain Injuries
Ear, Reconstruction and Salvage
Eyelid Anatomy
Initial Evaluation and Management of Maxillofacial Injuries
Orbit Anatomy
Related Medscape topics:
Resource Center Aesthetic Medicine
Resource Center Wound Management
Specialty Site Surgery
Most facial soft-tissue injuries are the result of direct trauma. The trauma can be a result of contact with another participant, sport-specific equipment, and/or the environment/playing surface.
Contusions
Facial Fractures
Nasal Fracture
Facial injuries in which there is significant bony tenderness or obvious deformity warrant imaging to evaluate for fractures. Start with plain films of the face, including Water, Caldwell, and lateral views. Panoramic x-ray images may also be of benefit. These images may also be helpful in the evaluation of a possible foreign body presence. If the clinical suspicion is high or plain films are inconclusive, computed tomography (CT) scans can be useful. If necessary, 3-dimensional (3-D) reconstructions can be made for a more detailed analysis.
Related Medscape topics:
Resource Center Trauma
Specialty Site Orthopaedics
Specialty Site Radiology
Facial soft-tissue injury complications include, but are not limited to, infection, hematoma, poor cosmesis, flap/wound edge necrosis, nasal septum necrosis, retained foreign body, cauliflower ear, and loss of function.
Severe injuries to the structures of the face often require consultation with a specialist. Evaluation by an ophthalmologist is needed for any penetrating globe injuries, enucleation, eyelid lacerations involving the lid margins or lacrimal apparatus, and injury that compromises visual acuity. In the event of a major deforming injury (eg, ear or nose avulsion) or when epistaxis cannot be controlled, consultation with an otolaryngologist is warranted. For any suspected or confirmed CSF leak, a neurosurgeon should be consulted. A plastic surgeon should evaluate any complex and potentially cosmetically disfiguring lacerations that may or may not include concomitant nerve injury.
Contusion
Contusions are the most common facial soft-tissue injury seen by a sports medicine team. They are usually the result of blunt trauma to the face. Ice should be applied for 10-20 minutes to minimize the immediate inflammatory response. This treatment should continue for the next 48-72 hours. Over-the-counter (OTC) nonsteroidal anti-inflammatory medications (NSAIDs) are good for symptom relief. Complications are uncommon.
Abrasion
Abrasions are partial-thickness disruptions of the epidermis as a result of sudden, forcible friction. These wounds should be gently cleansed of all debris. Failure to remove all debris can lead to "tattooing" of the skin and a poor cosmetic result. Local or regional anesthetic may be required to keep the patient comfortable and achieve adequate cleaning. Lubrication of the wound using an antibiotic ointment and covering with a sterile bandage may encourage healing.
Corneal abrasion
Corneal abrasions result from loss of the surface epithelium. Disruption near the central visual axis interferes with visual acuity. Such abrasions should be treated with a course of ophthalmic topical antibiotics. Topical analgesics may be used initially, but avoid prescribing them to the athlete for home use because this may delay reepithelialization and suppress the normal blink reflex. Note: Emergent consultation with an ophthalmologist is warranted for suspected retained intraocular foreign bodies. Urgent consultation is needed for suspected corneal ulcerations (microbial keratitis). These injuries require close follow-up, and referral to an ophthalmologist should also be made for any athlete with continued pain after 48 hours or inadequate healing by 72 hours.
Epistaxis
Epistaxis typically does not require invasive treatment. Most often, bleeding can be controlled by maintaining continuous pressure for 10 minutes. This is achieved by asking the athlete to grasp and pinch his or her nose. While this task is performed, have the athlete tilt the head forward to avoid bleeding into the pharynx, which can lead to aspiration. Pressure should be maintained for at least 5 minutes and up to 20 minutes. If this is unsuccessful, a second attempt should be made.
Packing the affected nostril with gauze soaked in topical decongestant may be necessary to achieve hemostasis. If the bleeding site is clearly observed, chemical cautery can be attempted using silver nitrate directly at the site. If bleeding is not controlled despite these measures, the nasal cavity should be packed from posterior to anterior with ribbon gauze impregnated with petroleum jelly. Nasal tampons may also be helpful. For particularly resistant cases, referral to an otolaryngologist may be required.
Not all facial soft-tissue injuries require pharmacotherapy. When used, the goal is to decrease the potential morbidity and mortality and/or reduce the chance for complications.
Toxoids are used to induce active immunity.
Related Medscape topic:
Resource Center Vaccines
Induce active immunity against tetanus in selected patients. The immunizing agents of choice for most adults and childrenaged >7 y are the tetanus and diphtheria toxoids. It is necessary to administer booster doses to maintain tetanus immunity throughout life.
Pregnant patients should receive only tetanus toxoid, not a diphtheria antigen–containing product.
In children and adults, tetanus toxoid may be administered into the deltoid or midlateral thigh muscles. In infants, the preferred site is the mid thigh laterally.
Administer dT 0.5 mL IM to patients aged >7 y who have not been immunized within 5 y. Administer tetanus IgG (250 U) at a different site for patients with an incomplete immunization history.
Primary immunization: 0.5 mL IM; give 2 injections 4-8 wk apart and a third dose 6-12 mo after second injection
Booster dose: 0.5 mL q10y
Administer as in adults
Patients receiving immunosuppressants, including corticosteroids or radiation therapy, may remain susceptible despite immunization because of poor immune responses; cimetidine may enhance or augment delayed hypersensitivity responses to skin-test antigens; avoid concurrent use of medications with systemic chloramphenicol because it may impair amnestic response to tetanus toxoid; concurrent use of tetanus immune globulin may delay development of active immunity by several days (this interaction is nevertheless clinically insignificant and does not preclude its concurrent use).
Documented hypersensitivity; history of any type of neurologic symptoms or signs following administration; the FDA recommends deferral of elective tetanus immunization during any outbreak of poliomyelitis because tetanus toxoid injections are an important cause of provocative poliomyelitis
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Do not use to treat actual tetanus infections or for immediate prophylaxis of unimmunized individuals (instead, use tetanus antitoxin, preferably human tetanus immune globulin); diminished antibody response to active immunization may be seen in patients receiving immunosuppressive therapy; it is better to defer primary diphtheria immunization until immunosuppressive therapy is discontinued; routine immunization of symptomatic and asymptomatic HIV-infected persons is recommended.
Immunoglobulins are used for passive immunization, consisting of the administration of immunoglobulin that is pooled from the serum of immunized subjects.
Related eMedicine topic:
Intravenous Immunoglobulin
Related Medscape topic:
Resource Center Allergy & Clinical Immunology
Induces passive immunization in any person with a wound that might be contaminated with tetanus spores.
Prophylaxis: 250-500 U IM in opposite extremity to the tetanus toxoid lesion
Prophylaxis: 250 U IM in opposite extremity to the tetanus toxoid
None reported
Because antibodies in the globulin preparation may interfere with immune response to vaccination, do not administer within 3 mo of live virus immune globulin administration; it may be necessary to revaccinate persons who received immune globulin shortly after live virus vaccination.
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Persons with isolated IgA deficiency have the potential for developing antibodies to IgA and could have anaphylactic reactions to subsequent administration of blood products that contain IgA; do not perform skin testing because intradermal injection of concentrated gamma globulin may cause localized inflammation and can be misinterpreted, causing the medication to be withheld from a patient who is not allergic to this material; true allergic responses to human gamma globulin given in the prescribed IM manner are extremely rare; do not admix with other medications because this is usually incompatible.
Antibiotics are not recommended as part of routine wound care, particularly with the increasing number of multidrug-resistant bacteria. Empiric treatment is still recommended for wounds that are at high risk of infection. Large intraoral wounds may require treatment with penicillin. Bite injuries from a cat, dog, or human should be covered with amoxicillin/clavulanate or doxycycline and/or cefuroxime.
Because of a change in resistance patterns, cephalexin and dicloxacillin are no longer recommended for empiric treatment in many areas of the country. Methicillin-resistant Staphylococcus aureus (MRSA) is becoming increasingly problematic in community-acquired infections, and treatment should be based on the community resistance pattern (usually available from local hospitals or infectious disease specialists). When organism sensitivities are unknown, vancomycin should be considered until culture and sensitivity testing can be performed.
Related eMedicine topic:
MRSA Skin Infection in Athletes
Related Medscape topics:
Resource Center Emerging and Reemerging Infectious Diseases
Resource Center Sepsis
Specialty Site Infectious Diseases
Interferes with synthesis of cell wall mucopeptide during active multiplication, resulting in bactericidal activity against susceptible microorganisms.
1.2 million U IM (single dose)
25,000-50,000 U/kg IM; not to exceed 1.2 million U/dose
Probenecid can increase the effects; coadministration of tetracyclines can decrease the effects.
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Caution in the presence of impaired renal function
Inhibits biosynthesis of cell wall mucopeptide. Bactericidal against sensitive organisms when adequate concentrations are achieved and most effective during the stage of active multiplication. Inadequate concentrations may produce only bacteriostatic effects.
500 mg PO q6h for 5-7d
<12 years: 25-50 mg/kg/d PO divided tid/qid up to 3 g/d
>12 years: Administer as in adults
Probenecid may increase the effectiveness by decreasing clearance; tetracyclines are bacteriostatic, causing a decrease in the effectiveness of penicillins when administered concurrently.
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Caution in the presence of renal impairment
Drug combination treats bacteria that are resistant to beta-lactam antibiotics. For children aged >3 mo, base the dosing protocol on the amoxicillin content. Because of different ratios of amoxicillin to clavulanic acid in the 250-mg tab (250/125) vs the 250-mg chewable tab (250/62.5), do not use the 250-mg tab until child weighs >40 kg
500-875 mg PO q12h or 250-500 mg PO q8h
<40 kg: 20-40 mg/kg/d PO divided bid
>40 kg: Administer as in adults
Coadministration with warfarin or heparin increases the risk of bleeding.
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Administer for a minimum of 10 d to eliminate the organism and prevent sequelae (eg, endocarditis, rheumatic fever); following treatment, perform cultures to confirm eradication of streptococci.
Broad-spectrum, synthetically derived bacteriostatic antibiotic in the tetracycline class. Almost completely absorbed, concentrates in bile, and is excreted in urine and feces as a biologically active metabolite in high concentrations.
Inhibits protein synthesis and, thus, bacterial growth by binding to 30S and possibly the 50S ribosomal subunits of susceptible bacteria. May block dissociation of peptidyl t-RNA from ribosomes, causing RNA-dependent protein synthesis to arrest.
100 mg PO bid
<8 years: Not recommended
>8 years: 2-5 mg/kg/d PO in 1-2 divided doses; not to exceed 200 mg/d
The bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase the hypoprothrombinemic effects of anticoagulants; tetracyclines can decrease the effects of oral contraceptives, causing breakthrough bleeding and an increased risk of pregnancy.
Documented hypersensitivity; severe hepatic dysfunction
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce the dose in the presence of renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines.
Second-generation cephalosporin that maintains gram-positive activity of first-generation cephalosporins; adds activity against Proteus mirabilis, Haemophilus influenzae, Escherichia coli, Klebsiella pneumoniae, and Moraxella catarrhalis.
Binds to penicillin-binding proteins and inhibits final transpeptidation step of peptidoglycan synthesis, resulting in cell wall death. The condition of the patient, severity of the infection, and susceptibility of the microorganism determine the proper dose and route of administration. Resists degradation by beta-lactamase.
500 mg PO bid
15-30 mg/kg/d PO divided bid; not to exceed 500 mg/dose
Disulfiramlike reactions may occur when alcohol is consumed within 72 h after taking cefuroxime; may increase the hypoprothrombinemic effects of anticoagulants; may increase nephrotoxicity in patients receiving potent diuretics (eg, loop diuretics); coadministration with aminoglycosides increases the nephrotoxic potential
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Reduce the dosage by half if CrCl is 10-30 mL/min and by three quarters if it is <10 mL/min (high doses may cause CNS toxicity); bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged or repeated therapy.
Potent antibiotic directed against gram-positive organisms and active against Enterococcus species. Useful in the treatment of septicemia and skin structure infections. Indicated for patients who are unable to receive or whose infections have not responded to penicillins and cephalosporins or for infections with resistant staphylococci. Use CrCl to adjust the dose in patients diagnosed with renal impairment.
0.5 g IV q6h or 1 g IV q24h
Neonates:
<7 days and >2000 g: 30 mg/kg/d IV divided q12h
>7 days and >2000 g: 45 mg/kg/d IV divided q8h
<1 month and <1200 g: 15 mg/kg/d IV q24h
<1 month and 1200-2000 g: 20-30 mg/kg/d IV divided q12-18h
Infants >1 month and children: 40 mg/kg/d IV divided q8h
Seriously ill cancer patients and patients with suspected infection of the CNS: 60 mg/kg/d IV divided q6h
The necessity of monitoring the drug levels is debated; in order to achieve adequate therapeutic level in severe infections, the upper range of the peak (40 mcg/mL) should be reached.
Erythema, histaminelike flushing, and anaphylactic reactions may occur when administered with anesthetic agents; taken concurrently with aminoglycosides, the risk of nephrotoxicity may increase above that with aminoglycoside monotherapy; effects in neuromuscular blockade may be enhanced when coadministered with nondepolarizing muscle relaxants.
Documented hypersensitivity
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Caution in the presence of renal failure or neutropenia; "red man" syndrome is caused by IV infusion that is too rapid (dose given over a few minutes) but rarely happens when the dose given IV is over 2 h administration or as PO or IP administration; red man syndrome is not an allergic reaction
Return to play should be based on the location and severity of the injury, sport and position requirements, and risk of the injury causing a concomitant injury. Most athletes are able to return to play immediately after treatment on the sideline or in the training room. When making return-to-play decisions, attention should be given to whether the area in question can be protected from further injury.
Related Medscape topic:
Resource Center Exercise and Sports Medicine
See Medical Issues/Complications for a list of potential complications.
The use of protective equipment, such as helmets and headgear, face masks, eye protection (shields or goggles), and mouthpieces are useful in preventing some types of facial soft-tissue injuries. Importantly, make sure the rules of the sport allow for the use of such protective equipment before recommending or providing the protective equipment.
The prognosis for most facial soft-tissue injuries is good; the injuries usually heal rapidly, allowing the athlete to return to play. Knowing the expectations of the athlete and the athlete's family is important to ensure the treatment result is optimal.
Proper home wound care should be clearly explained to the patient and his or her family.
More so in facial injuries than injury to any other part of the body, the biggest pitfall from a medicolegal standpoint is a poor cosmetic outcome. Others include missed a foreign body, unrecognized nerve injury, wound infection, and premature return to play.
Related Medscape topics:
Resource Center Aesthetic Medicine
Resource Center Exercise and Sports Medicine
Resource Center Medical Malpractice and Legal Issues
Resource Center Sepsis
Papakosta V, Koumoura F, Mourouzis C. Maxillofacial injuries sustained during soccer: incidence, severity and risk factors. Dent Traumatol. Apr 2008;24(2):193-6. [Medline].
Roccia F, Diaspro A, Nasi A, Berrone S. Management of sport-related maxillofacial injuries. J Craniofac Surg. Mar 2008;19(2):377-82. [Medline].
ADA Council on Access, Prevention, and Interprofessional Relations; ADA Council on Scientific Affairs. Using mouthguards to reduce the incidence and severity of sports-related oral injuries. J Am Dent Assoc. Dec 2006;137(12):1712-20; quiz 1731. [Medline]. [Full Text].
Echlin PS, Upshur RE, Peck DM, Skopelja EN. Craniomaxillofacial injury in sport: a review of prevention research. Br J Sports Med. May 2005;39(5):254-63. [Medline]. [Full Text].
Romeo SJ, Hawley CJ, Romeo MW, Romeo JP. Facial injuries in sports. A team physician's guide to diagnosis and treatment. Phys Sportsmed. Apr 2005;33(4):[Full Text].
Stackhouse T. On-site management of nasal injuries. Phys Sportsmed. Aug 1998;26(8):[Full Text].
Kaufman BR, Heckler FR. Sports-related facial injuries. Clin Sports Med. Jul 1997;16(3):543-62. [Medline].
Beam JW. Tissue adhesives for simple traumatic lacerations. J Athl Train. Apr-Jun 2008;43(2):222-4. [Medline].
Barr A, Baines PS, Desai P, MacEwen CJ. Ocular sports injuries: the current picture. Br J Sports Med. Dec 2000;34(6):456-8. [Medline]. [Full Text].
Bodor RM, Breithaupt AD, Buncke GM, Bailey JR, Buncke HJ. Swimmer's nose deformity. Ann Plast Surg. Jun 2008;60(6):658-60. [Medline].
Capão Filipe JA, Rocha-Sousa A, Falcão-Reis F, Castro-Correia J. Modern sports eye injuries. Br J Ophthalmol. Nov 2003;87(11):1336-9. [Medline]. [Full Text].
Curtin JW. Basic plastic surgical techniques in repair of facial lacerations. Surg Clin North Am. Feb 1973;53(1):33-46. [Medline].
facial soft-tissue injuries, facial trauma, facial injury, facial fracture, face injury, cauliflower ear, subperichondrial hematoma, sports-related soft-tissue injury, facial laceration, facial abrasion, broken nose, epistaxis, facemask, face mask, maxillofacial trauma, maxillofacial injury, lip laceration, lip injury, eyelid injury, scalp injury, tongue injury, tongue laceration, corneal abrasion
Kyle D Parish, MD, Private Practice, Family Medicine and Sports Medicine
Kyle D Parish, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, and American Medical Society for Sports Medicine
Disclosure: Nothing to disclose.
Valerie E Cothran, MD, Assistant Professor, Department of Family and Community Medicine, Director of Primary Care Sports Medicine Fellowship, University of Maryland School of Medicine; Assistant Team Physician, University of Maryland
Valerie E Cothran, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, and American Medical Society for Sports Medicine
Disclosure: Nothing to disclose.
Gerard A Malanga, MD, Founder and Director, New Jersey Sports Medicine Institute; Director of Pain Management, Overlook Hospital; Director of Sports Medicine, Sports Medicine Fellowship Director, Mountainside Hospital; Clinical Chief, Rehabilitation Medicine and Electrodiagnosis, St Michael's Medical Center; Medical Director, Consultant, Horizon Healthcare Worker's Compensation Services, Blue Cross and Blue Shield Worker's Compensation
Gerard A Malanga, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Physical Medicine and Rehabilitation, American College of Sports Medicine, North American Spine Society, and Physiatric Association of Spine, Sports and Occupational Rehabilitation
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Russell D White, MD, Professor of Medicine, Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center Lakewood
Disclosure: Nothing to disclose.
Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital
Jon B Whitehurst, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America
Disclosure: Nothing to disclose.
Craig C Young, MD, Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical Director of Sports Medicine, Sports Medicine Fellowship Director, Medical College of Wisconsin
Craig C Young, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Society for Sports Medicine, Phi Beta Kappa, and Wilderness Medical Society
Disclosure: Nothing to disclose.
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)